Stock listing
BLSM Stock Price, News, Filings & Events — Blossomhill Therapeutics, Inc.
Selected listing: BLSM · NASDAQ · USD · US
This page tracks Blossomhill Therapeutics, Inc.'s BLSM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BLSM:NASDAQ. BLSM:NASDAQ is the stock-level entry point for investors researching Blossomhill Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Blossomhill Therapeutics, Inc. (BLSM) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- BLSM:NASDAQ
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Blossomhill Therapeutics, Inc. BLSM:NASDAQ stock context
This page tracks Blossomhill Therapeutics, Inc.'s BLSM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BLSM:NASDAQ. BLSM:NASDAQ is the stock-level entry point for investors researching Blossomhill Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Blossomhill Therapeutics, Inc. (BLSM) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Blossomhill Therapeutics, Inc.
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, i...
September 1, 2026
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advan...
August 18, 2026
Research Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for BLSM:NASDAQ.
Blossomhill Therapeutics, Inc. company profile
View the public company page for Blossomhill Therapeutics, Inc. on 6ix.
Blossomhill Therapeutics, Inc. news
Read company news and market updates connected to Blossomhill Therapeutics, Inc..
Blossomhill Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Blossomhill Therapeutics, Inc..